Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Background: Policymakers have recognized that proprietary patent medicine vendors (PPMVs) can provide an opportunity for efective scaling up of artemisinin-based combination therapy (ACT) since they constitute a major source of malaria treatment in Nigeria. This study was designed to determine the s...
| Format: | Article |
|---|---|
| Published: |
2020
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|